Back to Search
Start Over
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
- Source :
- PLoS ONE, PLoS ONE, Vol 5, Iss 4, p e10254 (2010)
- Publication Year :
- 2010
- Publisher :
- Public Library of Science (PLoS), 2010.
-
Abstract
- Background: The V3 loop of the HIV-1 envelope (Env) glycoprotein gp120 was identified as the ‘‘principal neutralizing domain’’ of HIV-1, but has been considered too variable to serve as a neutralizing antibody (Ab) target. Structural and immunochemical data suggest, however, that V3 contains conserved elements which explain its role in binding to virus coreceptors despite its sequence variability. Despite this evidence of V3 conservation, the ability of anti-V3 Abs to neutralize a significant proportion of HIV-1 isolates from different subtypes (clades) has remained controversial. Methods: HIV-1 neutralization experiments were conducted in two independent laboratories to test human anti-V3 monoclonal Abs (mAbs) against pseudoviruses (psVs) expressing Envs of diverse HIV-1 subtypes from subjects with acute and chronic infections. Neutralization was defined by 50% inhibitory concentrations (IC50), and was statistically assessed based on the area under the neutralization titration curves (AUC). Results: Using AUC analyses, statistically significant neutralization was observed by $1 anti-V3 mAbs against 56/98 (57%) psVs expressing Envs of diverse subtypes, including subtypes A, AG, B, C and D. Even when the 10 Tier 1 psVs tested were excluded from the analysis, significant neutralization was detected by $1 anti-V3 mAbs against 46/88 (52%) psVs from diverse HIV-1 subtypes. Furthermore, 9/24 (37.5%) Tier 2 viruses from the clade B and C standard reference panels were neutralized by $1 anti-V3 mAbs. Each anti-V3 mAb tested was able to neutralize 28–42% of the psVs tested. By IC50 criteria, 40/98 (41%) psVs were neutralized by $1 anti-V3 mAbs. Conclusions: Using standard and new statistical methods of data analysis, 6/7 anti-V3 human mAbs displayed cross-clade neutralizing activity and revealed that a significant proportion of viruses can be neutralized by anti-V3 Abs. The new statistical method for analysis of neutralization data provides many advantages to previously used analyses.
- Subjects :
- medicine.drug_class
lcsh:Medicine
HIV Infections
Cross Reactions
HIV Envelope Protein gp120
V3 loop
Biology
Antibodies, Viral
Monoclonal antibody
Virus
Neutralization
03 medical and health sciences
Receptors, HIV
Immunology/Immunity to Infections
medicine
Humans
lcsh:Science
Neutralizing antibody
Virology/Vaccines
Conserved Sequence
030304 developmental biology
chemistry.chemical_classification
0303 health sciences
Multidisciplinary
030306 microbiology
lcsh:R
Antibodies, Monoclonal
Infectious Diseases/HIV Infection and AIDS
Antibodies, Neutralizing
Virology
Peptide Fragments
3. Good health
chemistry
Area Under Curve
Data Interpretation, Statistical
Immunology/Immune Response
Monoclonal
Immunology
HIV-1
biology.protein
lcsh:Q
Virology/Host Antiviral Responses
Antibody
Glycoprotein
Research Article
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- PLoS ONE
- Accession number :
- edsair.doi.dedup.....a5e476582f43acaa5f0cb54718dc50dc
- Full Text :
- https://doi.org/10.1371/journal.pone.0010254